PL3270923T3 - Środek terapeutyczny na zaburzenie czynności płata czołowego - Google Patents
Środek terapeutyczny na zaburzenie czynności płata czołowegoInfo
- Publication number
- PL3270923T3 PL3270923T3 PL16765135T PL16765135T PL3270923T3 PL 3270923 T3 PL3270923 T3 PL 3270923T3 PL 16765135 T PL16765135 T PL 16765135T PL 16765135 T PL16765135 T PL 16765135T PL 3270923 T3 PL3270923 T3 PL 3270923T3
- Authority
- PL
- Poland
- Prior art keywords
- disorder
- therapeutic agent
- frontal lobe
- lobe
- frontal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015055532 | 2015-03-19 | ||
| PCT/JP2016/059788 WO2016148308A1 (en) | 2015-03-19 | 2016-03-18 | Therapeutic agent for frontal lobe dysfunction |
| EP16765135.5A EP3270923B1 (en) | 2015-03-19 | 2016-03-18 | Therapeutic agent for frontal lobe dysfunction |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3270923T3 true PL3270923T3 (pl) | 2021-12-20 |
Family
ID=56919157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16765135T PL3270923T3 (pl) | 2015-03-19 | 2016-03-18 | Środek terapeutyczny na zaburzenie czynności płata czołowego |
Country Status (38)
| Country | Link |
|---|---|
| US (2) | US20180042910A1 (pl) |
| EP (1) | EP3270923B1 (pl) |
| JP (1) | JP6869893B2 (pl) |
| KR (1) | KR20170129764A (pl) |
| CN (1) | CN107405341A (pl) |
| AR (1) | AR103972A1 (pl) |
| AU (1) | AU2016234211B2 (pl) |
| BR (1) | BR112017018165A2 (pl) |
| CA (1) | CA2978426A1 (pl) |
| CL (1) | CL2017002351A1 (pl) |
| CO (1) | CO2017008814A2 (pl) |
| CR (1) | CR20170405A (pl) |
| CY (1) | CY1124459T1 (pl) |
| DK (1) | DK3270923T3 (pl) |
| DO (1) | DOP2017000206A (pl) |
| EA (1) | EA032511B1 (pl) |
| EC (1) | ECSP17069712A (pl) |
| ES (1) | ES2884846T3 (pl) |
| GE (2) | GEP20197007B (pl) |
| HR (1) | HRP20211340T1 (pl) |
| HU (1) | HUE055387T2 (pl) |
| IL (1) | IL254196A0 (pl) |
| JO (1) | JO3544B1 (pl) |
| LT (1) | LT3270923T (pl) |
| MX (1) | MX381277B (pl) |
| MY (1) | MY196076A (pl) |
| PE (1) | PE20171621A1 (pl) |
| PL (1) | PL3270923T3 (pl) |
| PT (1) | PT3270923T (pl) |
| RS (1) | RS62311B1 (pl) |
| SG (1) | SG11201707012YA (pl) |
| SI (1) | SI3270923T1 (pl) |
| SV (1) | SV2017005527A (pl) |
| TN (1) | TN2017000369A1 (pl) |
| TW (1) | TWI723012B (pl) |
| UA (1) | UA123578C2 (pl) |
| WO (1) | WO2016148308A1 (pl) |
| ZA (1) | ZA201706136B (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113016719B (zh) * | 2019-12-24 | 2022-08-02 | 复旦大学附属华山医院 | 一种突触核蛋白病理性快动眼睡眠行为障碍模型的制备法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69834500T2 (de) | 1997-09-05 | 2007-05-03 | Kyowa Hakko Kogyo Co., Ltd. | Xanthinderivative zur behandlung von hirnischämie |
| JP4638355B2 (ja) | 2003-12-26 | 2011-02-23 | 協和発酵キリン株式会社 | チアゾール誘導体 |
| EP2210891A1 (en) * | 2009-01-26 | 2010-07-28 | Domain Therapeutics | New adenosine receptor ligands and uses thereof |
| TWI548411B (zh) * | 2009-04-28 | 2016-09-11 | Kyowa Hakko Kirin Co Ltd | Exercise disorder treatment |
| UA113383C2 (xx) * | 2009-09-02 | 2017-01-25 | Терапевтичний агент для лікування тривожних розладів | |
| UA110097C2 (uk) * | 2009-09-02 | 2015-11-25 | Терапевтичний агент для лікування розладів настрою | |
| WO2012060844A1 (en) * | 2010-11-05 | 2012-05-10 | Biotie Therapies, Inc | A2a antagonists as cognition and motor function enhancers |
-
2016
- 2016-03-17 JO JOP/2016/0045A patent/JO3544B1/ar active
- 2016-03-18 UA UAA201709985A patent/UA123578C2/uk unknown
- 2016-03-18 MX MX2017012020A patent/MX381277B/es unknown
- 2016-03-18 RS RS20211061A patent/RS62311B1/sr unknown
- 2016-03-18 PL PL16765135T patent/PL3270923T3/pl unknown
- 2016-03-18 HR HRP20211340TT patent/HRP20211340T1/hr unknown
- 2016-03-18 AU AU2016234211A patent/AU2016234211B2/en not_active Ceased
- 2016-03-18 EA EA201792070A patent/EA032511B1/ru unknown
- 2016-03-18 HU HUE16765135A patent/HUE055387T2/hu unknown
- 2016-03-18 MY MYPI2017703320A patent/MY196076A/en unknown
- 2016-03-18 AR ARP160100730A patent/AR103972A1/es unknown
- 2016-03-18 KR KR1020177026576A patent/KR20170129764A/ko not_active Withdrawn
- 2016-03-18 GE GEAP201614604A patent/GEP20197007B/en unknown
- 2016-03-18 WO PCT/JP2016/059788 patent/WO2016148308A1/en not_active Ceased
- 2016-03-18 EP EP16765135.5A patent/EP3270923B1/en active Active
- 2016-03-18 US US15/558,240 patent/US20180042910A1/en not_active Abandoned
- 2016-03-18 SI SI201631316T patent/SI3270923T1/sl unknown
- 2016-03-18 DK DK16765135.5T patent/DK3270923T3/da active
- 2016-03-18 PT PT167651355T patent/PT3270923T/pt unknown
- 2016-03-18 BR BR112017018165A patent/BR112017018165A2/pt not_active Application Discontinuation
- 2016-03-18 LT LTEP16765135.5T patent/LT3270923T/lt unknown
- 2016-03-18 CN CN201680012849.8A patent/CN107405341A/zh active Pending
- 2016-03-18 ES ES16765135T patent/ES2884846T3/es active Active
- 2016-03-18 CR CR20170405A patent/CR20170405A/es unknown
- 2016-03-18 PE PE2017001525A patent/PE20171621A1/es unknown
- 2016-03-18 SG SG11201707012YA patent/SG11201707012YA/en unknown
- 2016-03-18 GE GEAP201914604A patent/GEAP201914604A/en unknown
- 2016-03-18 JP JP2017547186A patent/JP6869893B2/ja not_active Expired - Fee Related
- 2016-03-18 TW TW105108544A patent/TWI723012B/zh not_active IP Right Cessation
- 2016-03-18 TN TNP/2017/000369A patent/TN2017000369A1/en unknown
- 2016-03-18 CA CA2978426A patent/CA2978426A1/en not_active Abandoned
-
2017
- 2017-08-29 SV SV2017005527A patent/SV2017005527A/es unknown
- 2017-08-29 IL IL254196A patent/IL254196A0/en unknown
- 2017-08-29 CO CONC2017/0008814A patent/CO2017008814A2/es unknown
- 2017-09-08 ZA ZA2017/06136A patent/ZA201706136B/en unknown
- 2017-09-11 DO DO2017000206A patent/DOP2017000206A/es unknown
- 2017-09-15 CL CL2017002351A patent/CL2017002351A1/es unknown
- 2017-10-18 EC ECIEPI201769712A patent/ECSP17069712A/es unknown
-
2021
- 2021-08-25 CY CY20211100762T patent/CY1124459T1/el unknown
- 2021-09-03 US US17/466,772 patent/US20210393606A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3328880T3 (da) | Terapeutiske midler | |
| EP3463464A4 (en) | ASSOCIATION TREATMENT | |
| PT3283527T (pt) | Terapêutica de combinação para o cancro | |
| EP3291824A4 (en) | ANTIMICROBIAL THERAPY | |
| LT3423103T (lt) | Pth provaistai | |
| GB201509893D0 (en) | Therapeutic agents | |
| HUE050705T2 (hu) | A rákos megbetegedések kezelésére szolgáló uridin diolaxán analógjai | |
| MA39483A (fr) | Agents thérapeutiques cibles | |
| EP3311841A4 (en) | ANTI CANCER AGENTS | |
| GB201517263D0 (en) | Therapeutic agents | |
| DK3258938T3 (da) | Phenothiazinanaloger som mitokondrie terapeutiske midler | |
| EP3307268A4 (en) | SUBSTITUTED PHENYLOXAZOLIDINONE FOR ANTIMICROBIAL THERAPY | |
| PL3259232T3 (pl) | Sposób na aerożele | |
| HUE060732T2 (hu) | Terápiás szer fibrózisra | |
| GB201509885D0 (en) | Therapeutic agents | |
| IL262851A (en) | Combination prime: boost therapy | |
| DK3393478T3 (da) | Kombinationsterapi | |
| EP3362091A4 (en) | COMBINATION THERAPY | |
| EP3308781A4 (en) | BLOOD PRESSURE CENTER | |
| GB201509888D0 (en) | Therapeutic agents | |
| EP3334447A4 (en) | CCK2R-drug conjugates | |
| EP3305294A4 (en) | AQUEOUS MEDICINE | |
| LT3324951T (lt) | Peritoninis terapinis skystis | |
| GB201513299D0 (en) | Therapeutic agents | |
| EP3349853A4 (en) | PRODRUGS OF FENCAMFAMINE |